INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

78,999 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
AG
Avanes GilbertEVP, CFO & Treasurer
RDIREADING INTERNATIONAL INC
Option exercise
M—
8,768 sh
Apr 18, 2026Apr 21, 2026
Page 1146 of 1975
← PrevNext →
traded Apr 18, 2026
+3d
SEC Form 4

Evidence

9
LD
Lanoy Jonathan DavidSVP, Chief Accounting Officer
NATRNATURES SUNSHINE PRODUCTS INC
Tax withholding
F$26K
951 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

9
LJ
Lodge-Jarrett JulieEVP, Chf People & Purpose Ofcr
DKSDICK'S SPORTING GOODS, INC.
Option exercise
M—
4,140 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

9
NC
Norman Daniel CEVP & President, Asia
NATRNATURES SUNSHINE PRODUCTS INC
Tax withholding
F$42K
1,567 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

9
KJ
Kemly Thomas J.Director, President & CEO
CLBKColumbia Financial, Inc.
Grant or award
A$1,858
100 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

9
SG
Schuknecht Seth GEVP, General Counsel
CVCOCAVCO INDUSTRIES, INC.
Tax withholding
F$22K
41 sh
Apr 18, 2026Apr 21, 2026
traded Apr 18, 2026
+3dSEC Form 4

Evidence

9
CS
Conine StevenDirector
WWayfair Inc.
Derivative conversion
C—
500.0K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

9
CW
Carll Thomas WayneVice President
ALOTAstroNova, Inc.
Option exercise
M—
210 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

9
CW
Carll Thomas WayneVice President
ALOTAstroNova, Inc.
Option exercise
M—
210 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

9
EB
Epperly Melissa B,Director
ROIVRoivant Sciences Ltd.
Grant or award
A—
670 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

9
SN
Shah NirajDirector, Chief Executive Officer
WWayfair Inc.
Derivative conversion
C—
500.0K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

9
KR
Kappus Anthony RayGM & Chief Operating Officer
UPWKUPWORK, INC
Grant or award
A—
22.6K sh
Apr 18, 2026Apr 21, 2026
traded Apr 18, 2026
+3dSEC Form 4

Evidence

9
GJ
Gotwals Philip JDirector
OABIOmniAb, Inc.
Option exercise
M—
13.3K sh
Apr 21, 2026Apr 21, 2026
traded Apr 21, 2026
+0dSEC Form 4

Evidence

8
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$117K
2,441 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

8
GJ
Garateix Ernie JDirector, Chief Executive Officer
HRTGHeritage Insurance Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$221K
8,034 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$115K
2,419 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$806K
1,398 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
WW
Wasechek WayneEVP and CFO
RYNRAYONIER INC
Open-market sale · 10b5-1 plan
SELL$62K
2,920 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
GL
Gibbons Mary LourdesSVP and Chief Legal Officer
ESNTEssent Group Ltd.
Open-market sale · 10b5-1 plan
SELL$55K
872 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

8
LJ
Lodge-Jarrett JulieEVP, Chf People & Purpose Ofcr
DKSDICK'S SPORTING GOODS, INC.
Gift
G—
150 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$885K
1,543 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
AC
Ames Sophie CExec. Vice President & CHRO
QBTSD-Wave Quantum Inc.
Open-market sale · 10b5-1 plan
SELL$66K
3,070 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
PP
Priest Brady PatrickCEO of Clover Care Services
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$79K
36.1K sh
Apr 18, 2026Apr 21, 2026
traded Apr 18, 2026
+3dSEC Form 4

Evidence

8
LB
Lewis BryanDirector, CEO/President
IDNIntellicheck, Inc.
Open-market sale · 10b5-1 plan
SELL$85K
10.0K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

7
SP
Sharma PankajChief Business Officer
RELYRemitly Global, Inc.
Option exercise · 10b5-1 plan
M—
10.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
BL
Bradbury Robyn LChief Financial Officer
CNMCore & Main, Inc.
Derivative conversion · 10b5-1 plan
C—
5,000 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
GL
Gibbons Mary LourdesSVP and Chief Legal Officer
ESNTEssent Group Ltd.
Open-market sale · 10b5-1 plan
SELL$481K
7,628 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

7
LC
Llewellyn Lindsay CatherineSEE REMARKS
LYFTLyft, Inc.
Open-market sale · 10b5-1 plan
SELL$355K
23.7K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
RJ
Riese Phillip JohnDirector
RELYRemitly Global, Inc.
Option exercise · 10b5-1 plan
M$26K
40.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
BJ
Binder Kurtis JosephCHIEF FINANCIAL OFFICER
ARLOArlo Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$380K
25.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

5
KE
Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Open-market sale · 10b5-1 plan
SELL$26K
536 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

5
GJ
Garateix Ernie JDirector, Chief Executive Officer
HRTGHeritage Insurance Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$8,521
300 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

5
MA
Modi Rajeev A.SEE REMARKS
ELANElanco Animal Health Inc
Grant or award
A$1,477
62 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

5
PM
Pearson MarkDirector, President and CEO
EQHEquitable Holdings, Inc.
Option exercise · 10b5-1 plan
M$630K
27.2K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

5
GS
Ganesan SatishSee Remarks
SYNASYNAPTICS Inc
Tax withholding · 10b5-1 plan
F$470K
5,862 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

5
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Tax withholding · 10b5-1 plan
F$443K
5,518 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$504K
880 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$581K
1,010 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$397K
687 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$254K
442 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence